 Wysłany: Śro 10:39, 22 Gru 2010 Temat postu: Puma Ferraris Sandals Chronic Kidney puma future c |
|
| />
Chronic Kidney Disease - Drug Pipeline Analysis and Market Forecasts to 2016 Summary Report on the pharmaceutical and healthcare industry - Chronic Kidney Disease - Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global chronic kidney disease market. This pharma report identifies the key trends shaping and driving the global chronic kidney disease market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global chronic kidney disease sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalDatas team of industry experts. Scope - Annualized global chronic kidney disease market revenues data from 2001 to 2009 Puma Ferraris Sandals, forecast forward for 7 years to 2016. - Geographies covered in this report include the US (United States), the UK (United Kingdom), Italy, Spain, Germany, France and Japan. - Pipeline analysis data split across different phases by mechanism of action and emerging trends. Key classes of mechanism of action phosphate binders, erythropoietin (EPO) activators, nutrition supplements, iron replacement therapy, PTH synthesis inhibitor, Angiotensin Converting Enzyme (ACE) Inhibitor, endothelin antagonist, Angiotensin II Receptor Blocker puma future cat, Antioxidant Inflammation Modulator Puma Disc, Direct renin inhibitor, IMPDH Inhibitor, Hypoxia-inducible factor (HIF) prolyl hydroxylase (PH) inhibitor. - Analysis of the current and future competition in the global chronic kidney disease market. Key market players covered include Reata Pharmaceuticals, Keryx Pharmaceuticals, Cytochroma Inc, Affymax, Ineos Healthcare, Merck & Co Inc, Pfizer, Novartis AG, Amgen and Abbott Plc. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future chronic kidney disease market. For more information, please visit: /reports/Chronic-Kidney-Disease-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016-39189.html Or email us at press@aarkstore.com or call +919272852585 Aarkstore Enterprise Tel : +912227453309 Mobile No: +919272852585 Email : contact@aarkstore.com Website : Blog: / Follow us on twitter: /aarkstoredotcom 相关的主题文章： Accounting Software For Nonprofit Create Your Custom Own Shoes In A Simple And Easy Way Puma Fluxion II Card Embossing Mac Puma Mihara MY |
|
